Radhakrishnan Srikanth sold $3K of LUNG
Radhakrishnan Srikanth (Chief Science &Techn. Officer) sold 2,153 shares of Pulmonx Corp (LUNG) at $1.54 on 2026-06-01.
How this was made
The 30-second read
Why it matters
Insider selling disclosures can influence short-term sentiment, but without accompanying fundamental updates (earnings, trial results, guidance, deals) the trading signal is typically weak.
Market read
A routine insider sale disclosure; likely limited incremental impact on valuation absent other catalysts.
What to watch
The sale is under an open-market transaction and the filing notes no pre-arranged 10b5-1 plan, but the disclosed value is small and not clearly tied to a broader change.
Background
The article is an SEC insider transaction (Form 4) disclosure for Pulmonx Corp.
Ticker impact
Pulmonx insider Form 4 shows CSO Radhakrishnan Srikanth sold 2,153 shares in an open-market transaction on 2026-06-01.
Low near-term impact; any move is likely sentiment-driven and should be weighed against overall tape/volume.
The filing is a routine insider transaction with small dollar value (~$3.3K) and no stated link to new company fundamentals.
Market effects
Minimal; single-company insider transaction without sector-wide signal.
None indicated.
None indicated.
Counterpoint
Insider sales can be planned for diversification or liquidity needs and may not reflect negative views on the business.
Key entities
- issuerPulmonx Corp
US-listed company (LUNG) whose insider transaction was disclosed via SEC Form 4.
- insiderRadhakrishnan Srikanth
Chief Science & Techn. Officer who sold 2,153 shares at $1.5400/share.
